Showing 1 - 4 results of 4 for search '"Cancer staging"', query time: 0.11s Refine Results
  1. 1

    Prediagnostic concentrations of plasma genistein and prostate cancer risk in 1,605 men with prostate cancer and 1,697 matched control participants in EPIC. by Travis, R, Allen, N, Appleby, P, Price, A, Kaaks, R, Chang-Claude, J, Boeing, H, Aleksandrova, K, Tjønneland, A, Johnsen, N, Overvad, K, Ramón Quirós, J, González, C, Molina-Montes, E, Sánchez, M, Larrañaga, N, Castaño, J, Ardanaz, E, Khaw, K, Wareham, N, Trichopoulou, A, Karapetyan, T, Rafnsson, S, Palli, D, Krogh, V

    Published 2012
    “…There was no evidence of heterogeneity in this association by age at blood collection, country of recruitment, or cancer stage or histological grade. CONCLUSION: Plasma genistein concentration was not associated with prostate cancer risk in this large cohort of European men.…”
    Journal article
  2. 2

    Plasma phyto-oestrogens and prostate cancer in the European Prospective Investigation into Cancer and Nutrition. by Travis, R, Spencer, E, Allen, N, Appleby, P, Roddam, A, Overvad, K, Johnsen, N, Olsen, A, Kaaks, R, Linseisen, J, Boeing, H, Nöthlings, U, Bueno-de-Mesquita, H, Ros, M, Sacerdote, C, Palli, D, Tumino, R, Berrino, F, Trichopoulou, A, Dilis, V, Trichopoulos, D, Chirlaque, MD, Ardanaz, E, Larranaga, N, Gonzalez, C

    Published 2009
    “…There was no evidence of heterogeneity in these results by age at blood collection or country of recruitment, nor by cancer stage or grade. These results suggest that higher concentrations of circulating genistein may reduce the risk of prostate cancer but do not support an association with plasma lignans.…”
    Journal article
  3. 3
  4. 4